Position in AZN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$36,543,756
-$1,146,366 QoQ
Shares Held
192,721
+0.8% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#179
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $468,730,500 across 16 Drug Manufacturers - General names. AZN ranks #5 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
248,532 | $89,998,407 | |
| 2 | LLY |
ELI LILLY & Co
|
65,278 | $78,296,398 | |
| 3 | NVS |
Novartis AG
|
442,978 | $69,423,512 | |
| 4 | JNJ |
Johnson & Johnson
|
156,545 | $39,757,733 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
192,721 | $36,543,756 | |
| 6 | MRK |
Merck & Co., Inc.
|
252,444 | $32,439,054 | |
| 7 | ABBV |
AbbVie Inc.
|
123,655 | $31,116,544 | |
| 8 | GSK |
GSK plc
|
551,436 | $28,906,275 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,543,756 | 192,721 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $37,690,122 | 191,107 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||